Physicochemical Properties
| Molecular Formula | C4H7NAO3 |
| Molecular Weight | 126.09 |
| CAS # | 13613-65-5 |
| Related CAS # | (R)-3-Hydroxybutanoic acid-13C2 sodium;202114-54-3;(R)-3-Hydroxybutanoic acid-13C4 sodium;2483735-72-2;(R)-3-Hydroxybutanoic acid,3-Hydroxybutanoic acid-13C sodium;(R)-3-Hydroxybutanoic acid-d3 sodium;(R)-3-Hydroxybutanoic acid (sodium) (Standard);13613-65-5 |
| Appearance | White to off-white solid powder |
| Boiling Point | 269.2ºCat 760 mmHg |
| Melting Point | 149-155ºC(lit.) |
| Flash Point | 121ºC |
| Vapour Pressure | 0.000979mmHg at 25°C |
| LogP | 0 |
| SMILES | [Na+].O([H])[C@]([H])(C([H])([H])[H])C([H])([H])C(=O)[O-] |
| Synonyms | (R)-(-)-3-Hydroxybutanoic acid sodium salt; (R)-(-)-3-Hydroxybutyric acid sodium |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment, avoid exposure to moisture. |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| Targets | Microbial Metabolite Human Endogenous Metabolite |
| ln Vitro | (R)-3-Hydroxybutanoic acid sodium is a metabolite derived from acetoacetate. Enhanced fatty acid oxidation in the liver leads to increased production of acetoacetate, which is then converted to (R)-3-Hydroxybutanoic acid sodium via a reaction catalyzed by 3-hydroxybutyrate dehydrogenase[1]. |
| References |
[1]. Ide T. Enzymatic-HPLC method to analyze D-3-hydroxybutyric acid in rat serum. Biosci Biotechnol Biochem. 2010;74(8):1578-82. [2]. Production of (R)-3-hydroxybutyric acid by Arxula adeninivorans. AMB Express. 2017 Dec;7(1):4. |
Solubility Data
| Solubility (In Vitro) |
H2O : ~100 mg/mL (~793.08 mM; with ultrasonication) DMSO : ~50 mg/mL (~396.54 mM; with ultrasonication (<60°C)) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (19.83 mM)(saturation unknown) in 10% DMSO 40% PEG300 5% Tween-80 45% Saline (add these co-solvents sequentially from left to right, and one by one),clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution and add it to 400 μL PEG300, mix well; then add 50 μL Tween-80 to the above system, mix well; then continue to add 450 μL of normal saline to make up to 1 mL. Preparation of normal saline: Dissolve 0.9 g of sodium chloride in ddH₂O and make up to 100 mL to obtain a clear and transparent normal saline solution. Solubility in Formulation 2: ≥ 2.5 mg/mL (19.83 mM)(saturation unknown) in 10% DMSO 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one),clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution and add it to 900 μL of 20% SBE-β-CD saline solution and mix well. 2 g SBE-β-CD (sulfobutyl ether β-cyclodextrin) powder is diluted to 10 mL of saline and completely dissolved until clear and transparent. Solubility in Formulation 3: ≥ 2.5 mg/mL (19.83 mM)(saturation unknown) in 10% DMSO 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one),clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution and add it to 900 μL corn oil and mix well. Solubility in Formulation 4: 100 mg/mL (793.08 mM) in PBS (add these co-solvents sequentially from left to right, and one by one),clear solution; with sonication.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 7.9308 mL | 39.6542 mL | 79.3084 mL | |
| 5 mM | 1.5862 mL | 7.9308 mL | 15.8617 mL | |
| 10 mM | 0.7931 mL | 3.9654 mL | 7.9308 mL |